Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Christopher J. Jolly is active.

Publication


Featured researches published by Christopher J. Jolly.


Immunological Reviews | 1998

Monitoring and interpreting the intrinsic features of somatic hypermutation

Michael S. Neuberger; Michael K Ehrenstein; Norman Klix; Christopher J. Jolly; José Yélamos; Cristina Rada; Cesar Milstein

Summary: We have used both normal and transgenic mice to analyse the recruitment and targeting of somatic hypermutation to the immunoglobulin loci. We compare methods for analysing hypermutation and discuss how large databases of mutations can be assembled by PCR amplification of the rearranged V‐gene flanks from the germinal centre B cells of normal mice as well as by transgene‐specific amplification from transgenic B cells. Such studies confirm that hypermutation is preferentially targeted to the immunoglobulin V gene with the bcl6 gene, for example, escaping this intense mutational targeting in germinal centre B cells. We review our data concerning the nature of the hypermutation domain and the targeting of hotspots within that domain. We consider how enhancer‐mediated recruitment of hypermutation to the immunoglobulin loci operates in a clonally maintained fashion and illustrate how both the degree of expression and demethylation of the transgene broadly correlate with its mutability.


Journal of Immunology | 2003

Reduced Switching in SCID B Cells Is Associated with Altered Somatic Mutation of Recombined S Regions

Adam Cook; Liana Oganesian; Pearly Harumal; Antony Basten; Robert Brink; Christopher J. Jolly

Deoxyribonucleic acid double-stranded breaks act as intermediates in Ig V(D)J recombination and probably perform a similar function in class switch recombination between IgH C genes. In SCID mice, V(D)J recombination is blocked because the DNA-dependent protein kinase catalytic subunit (DNA-PKcs) protein is defective. We show in this study that switching to all isotypes examined was detectable when the SCID mutation was introduced into anti-hen egg lysozyme transgenic B cells capable of undergoing class switch recombination, but switching was significantly reduced in comparison with control B cells of the same specificity lacking the RAG1 gene. Thus, DNA-PKcs is involved in switching to all isotypes, but plays a lesser role in the switching process than it does in V(D)J-coding joint formation. The higher level of switching observed by us in SCID B cells compared with that observed by others in DNA-PKcsnull cells raises the possibility that kinase-deficient DNA-PKcs can function in switching. Point mutation of G:C base pairs with cytidines on the sense strand was greatly reduced in recombined switch regions from SCID cells compared with control RAG1−/− B cells. The preferential loss of sense strand cytidine mutations from hybrid S regions in SCID cells suggests the possibility that nicks might form in S regions of activated B cells on the template strand independently of activation-induced cytidine deaminase and are converted to double-strand breaks when activation-induced cytidine deaminase deaminates the non-template strand.


European Journal of Immunology | 1998

Multiple sequences from downstream of the Jκ cluster can combine to recruit somatic hypermutation to a heterologous, upstream mutation domain

Norman Klix; Christopher J. Jolly; Sarah L. Davies; Marianne Brüggemann; Gareth T. Williams; Michael S. Neuberger

Recruitment of somatic hypermutation to the Igκ locus has previously been shown to depend on the enhancer elements, Ei/MAR and E3 ′ . Here we show that these elements are not sufficient to confer mutability. However, hypermutation is effectively targeted to a chimeric β‐globin/Igκ transgene whose 5 ′ end is composed of the human β‐globin gene (promoter and first two exons) and whose 3 ′ end consists of selected sequences derived from downstream of the Jκ cluster (Ei/MAR, Cκ + flank and E3 ′ ). Thus, multiple downstream Igκ sequences (all derived from 3 ′ of the Jκ cluster) can combine to recruit mutation to a heterologous mutation domain. The location of this hypermutation domain is defined by the position of the transcription start site and this applies even if the Igκ Ei/MAR is positioned upstream of the promoter. Hotspots within the mutation domain are, however, defined by local DNA sequence as evidenced by a new hotspot being created within the β‐globin domain by a mutation within the transgene. We propose that multiple, moveable Igκ sequences (that are normally located downstream of the transcription start site) cooperate to bring a hypermutation priming factor to the transcription initiation complex; a mutation domain is thereby created downstream of the promoter but the local sequence defines the detailed pattern of mutation within that domain.


Immunity | 2012

Elimination of Germinal-Center-Derived Self-Reactive B Cells Is Governed by the Location and Concentration of Self-Antigen

Tyani D. Chan; Katherine Wood; Jana R. Hermes; Danyal Butt; Christopher J. Jolly; Antony Basten; Robert Brink

Secondary diversification of the B cell repertoire by immunoglobulin gene somatic hypermutation in the germinal center (GC) is essential for providing the high-affinity antibody specificities required for long-term humoral immunity. While the risk to self-tolerance posed by inadvertent generation of self-reactive GC B cells has long been recognized, it has not previously been possible to identify such cells and study their fate. In the current study, self-reactive B cells generated de novo in the GC failed to survive when their target self-antigen was either expressed ubiquitously or specifically in cells proximal to the GC microenvironment. By contrast, GC B cells that recognized rare or tissue-specific self-antigens were not eliminated, and could instead undergo positive selection by cross-reactive foreign antigen and produce plasma cells secreting high-affinity autoantibodies. These findings demonstrate the incomplete nature of GC self-tolerance and may explain the frequent association of cross-reactive, organ-specific autoantibodies with postinfectious autoimmune disease.


Immunity | 2000

The Contribution of Somatic Hypermutation to the Diversity of Serum Immunoglobulin: Dramatic Increase with Age

Gareth T. Williams; Christopher J. Jolly; Jenny Köhler; Michael S. Neuberger

Although somatic mutation contributes to the diversity of only a minor fraction of B cells in mouse spleen or blood, its contribution to the diversity of serum immunoglobulin is unknown. We have devised an immunoassay to monitor mutated antibodies in serum using a monoclonal antibody that recognizes a VK only when mutated at its major intrinsic hot spot. Mutation makes essentially no contribution to the diversity of endogenous serum IgM, IgG, or IgA in young mice. However, in response to environmental antigens, the titer of mutated immunoglobulin in T cell-proficient mice rises strikingly with age, such that the major proportion of serum immunoglobulin in adults is somatically mutated, with the mutation load in IgG being some 10-fold greater than in IgM.


Journal of Experimental Medicine | 2012

Ectopic restriction of DNA repair reveals that UNG2 excises AID-induced uracils predominantly or exclusively during G1 phase

George Sharbeen; Christine Yee; Adrian L. Smith; Christopher J. Jolly

As revealed using an UNG2 inhibitor peptide fused to cell cycle–regulated degradation motifs, the cell cycle phase during which uracil residues are processed determines the fidelity of repair.


Immunology and Cell Biology | 2001

Somatic hypermutation of immunoglobulin κ transgenes: Association of mutability with demethylation

Christopher J. Jolly; Michael S. Neuberger

Following antigen encounter, immunoglobulin genes are diversified by somatic hypermutation. The mechanism by which this mutational process preferentially targets immunoglobulin genes is not known, but is likely linked to transcription. However, transcription is not sufficient to ensure mutability. Here, by polymerase chain reaction amplification of bisulfite‐modified DNA, the pattern of demethylation within the Igκ mutation domain is analysed and transgenes are used to identify an association between demethylation and mutability. In mice carrying an Igκ transgene that is well transcribed but only poorly targeted for hypermutation, the mutated transgene copies have been demethylated within the mutation domain, whereas the methylated copies remain unmutated. Thus, the hypermutation mechanism only acts on immunoglobulin gene targets that are demethylated as well as transcribed, although transcription and demethylation do not themselves guarantee mutability.


Small GTPases | 2014

ARHGAP18: an endogenous inhibitor of angiogenesis, limiting tip formation and stabilizing junctions

Garry Hk Chang; Angelina J. Lay; Ka Ka Ting; Y. N. Zhao; Paul R. Coleman; Elizabeth E. Powter; Ann Formaz-Preston; Christopher J. Jolly; Neil I. Bower; Benjamin M. Hogan; Silke Rinkwitz; Thomas S. Becker; Mathew A. Vadas; Jennifer R. Gamble

The formation of the vascular network requires a tightly controlled balance of pro-angiogenic and stabilizing signals. Perturbation of this balance can result in dysregulated blood vessel morphogenesis and drive pathologies including cancer. Here, we have identified a novel gene, ARHGAP18, as an endogenous negative regulator of angiogenesis, limiting pro-angiogenic signaling and promoting vascular stability. Loss of ARHGAP18 promotes EC hypersprouting during zebrafish and murine retinal vessel development and enhances tumor vascularization and growth. Endogenous ARHGAP18 acts specifically on RhoC and relocalizes to the angiogenic and destabilized EC junctions in a ROCK dependent manner, where it is important in reaffirming stable EC junctions and suppressing tip cell behavior, at least partially through regulation of tip cell genes, Dll4, Flk-1 and Flt-4. These findings highlight ARHGAP18 as a specific RhoGAP to fine tune vascular morphogenesis, limiting tip cell formation and promoting junctional integrity to stabilize the angiogenic architecture.


Journal of Experimental Medicine | 2008

Fixing DNA breaks during class switch recombination

Christopher J. Jolly; Adam Cook; John P. Manis

Immunoglobulin (Ig) class switch recombination (CSR) involves the breakage and subsequent repair of two DNA sequences, known as switch (S) regions, which flank IgH constant region exons. The resolution of CSR-associated breaks is thought to require the nonhomologous end-joining (NHEJ) DNA repair pathway, but the role of the NHEJ factor DNA-dependent protein kinase catalytic subunit (DNA-PKcs) in this process has been unclear. A new study, in which broken IgH-containing chromosomes in switching B cells were visualized directly, clearly demonstrated that DNA-PKcs and, unexpectedly, the nuclease Artemis are involved in the resolution of switch breaks.


PLOS Biology | 2007

DNA-Dependent Protein Kinase Inhibits AID-Induced Antibody Gene Conversion

Adam Cook; Joanna M. Raftery; K. K. Edwin Lau; Andrew Jessup; Reuben S. Harris; Shunichi Takeda; Christopher J. Jolly

Affinity maturation and class switching of antibodies requires activation-induced cytidine deaminase (AID)-dependent hypermutation of Ig V(D)J rearrangements and Ig S regions, respectively, in activated B cells. AID deaminates deoxycytidine bases in Ig genes, converting them into deoxyuridines. In V(D)J regions, subsequent excision of the deaminated bases by uracil-DNA glycosylase, or by mismatch repair, leads to further point mutation or gene conversion, depending on the species. In Ig S regions, nicking at the abasic sites produced by AID and uracil-DNA glycosylases results in staggered double-strand breaks, whose repair by nonhomologous end joining mediates Ig class switching. We have tested whether nonhomologous end joining also plays a role in V(D)J hypermutation using chicken DT40 cells deficient for Ku70 or the DNA-dependent protein kinase catalytic subunit (DNA-PKcs). Inactivation of the Ku70 or DNA-PKcs genes in DT40 cells elevated the rate of AID-induced gene conversion as much as 5-fold. Furthermore, DNA-PKcs-deficiency appeared to reduce point mutation. The data provide strong evidence that double-strand DNA ends capable of recruiting the DNA-dependent protein kinase complex are important intermediates in Ig V gene conversion.

Collaboration


Dive into the Christopher J. Jolly's collaboration.

Top Co-Authors

Avatar

Michael S. Neuberger

Laboratory of Molecular Biology

View shared research outputs
Top Co-Authors

Avatar

Adam Cook

Royal Prince Alfred Hospital

View shared research outputs
Top Co-Authors

Avatar

George Sharbeen

University of New South Wales

View shared research outputs
Top Co-Authors

Avatar

Norman Klix

Laboratory of Molecular Biology

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Robert Brink

Garvan Institute of Medical Research

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Cesar Milstein

Laboratory of Molecular Biology

View shared research outputs
Top Co-Authors

Avatar

Cristina Rada

Laboratory of Molecular Biology

View shared research outputs
Researchain Logo
Decentralizing Knowledge